Sofía C. Khouili
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Sofía C. Khouili has a total of 24 co-authors. Here are the top co-authors by number of shared publications:
- David Sancho
Centro Nacional de Investigaciones Cardiovasculares Carlos III (CNIC), Madrid, Spain
2 shared publications - Salvador Iborra
Department of Immunology, Ophthalmology and ENT, School of Medicine, Universidad Complutense de Madrid, Madrid, Spain
2 shared publications - Adrián Belinchón-García
Immunobiology Laboratory. Fundación Centro Nacional de Investigaciones Cardiovasculares Carlos III, Madrid, Spain
1 shared publication - Ana Redondo-Urzainqui
Centro Nacional de Investigaciones Cardiovasculares 3 , Madrid
1 shared publication - Annalaura Mastrangelo
Centro Nacional de Investigaciones Cardiovasculares (CNIC), Madrid, Spain
1 shared publication - Elena Hernández-García
Department of Immunology, Ophthalmology and ENT, School of Medicine, Universidad Complutense de Madrid, Madrid, Spain
1 shared publication
Latest Publications
- 29 May 2026
- Published by American Association for the Advancement of Science (AAAS) in Science Immunology
- Vol. 11 (119) , eaef0098
Mitochondrial complex I activity promotes antigen cross-presentation in dendritic cells
Mitochondrial metabolism modulates immune cell signaling, yet how individual electron transport chain complexes fine-tune dendritic cell (DC) function remains unclear. Here, we identify mitochondrial complex I (CI) as a critical metabolic checkpoint controlling antigen cross-presentation by DCs in mice. Deficiency of the CI subunit NDUFS4 in DCs led to the formation of a nonfunctional CI subcomplex, resulting in mildly impaired mitochondrial respiration without triggering a compensatory glycolytic shift. NDUFS4 deficiency limited endosomal escape of internalized antigens, thereby impairing antigen cross-presentation while largely preserving direct presentation. CI dysfunction lowered the NAD + /NADH ratio, concomitant with decreased ATP levels, and diminished neutral lipid storage and lipid peroxidation. Restoration of the NAD + /NADH ratio rescued cross-presentation in NDUFS4-deficient DCs. NDUFS2-deficient DCs showed similar defects in cross-presentation, which were also rescued by rebalancing the NAD + /NADH ratio. Together, these findings reveal a link between mitochondrial CI integrity, NAD + -driven redox metabolism, and antigen cross-presentation.
- 29 May 2026
- Published by American Association for the Advancement of Science (AAAS) in Science Immunology
- Vol. 11 (119) , eaef0098
Mitochondrial complex I activity promotes antigen cross-presentation in dendritic cells
Mitochondrial metabolism modulates immune cell signaling, yet how individual electron transport chain complexes fine-tune dendritic cell (DC) function remains unclear. Here, we identify mitochondrial complex I (CI) as a critical metabolic checkpoint controlling antigen cross-presentation by DCs in mice. Deficiency of the CI subunit NDUFS4 in DCs led to the formation of a nonfunctional CI subcomplex, resulting in mildly impaired mitochondrial respiration without triggering a compensatory glycolytic shift. NDUFS4 deficiency limited endosomal escape of internalized antigens, thereby impairing antigen cross-presentation while largely preserving direct presentation. CI dysfunction lowered the NAD + /NADH ratio, concomitant with decreased ATP levels, and diminished neutral lipid storage and lipid peroxidation. Restoration of the NAD + /NADH ratio rescued cross-presentation in NDUFS4-deficient DCs. NDUFS2-deficient DCs showed similar defects in cross-presentation, which were also rescued by rebalancing the NAD + /NADH ratio. Together, these findings reveal a link between mitochondrial CI integrity, NAD + -driven redox metabolism, and antigen cross-presentation.
- 25 November 2025
- Published by Rockefeller University Press in Journal of Experimental Medicine
- Vol. 223 (2)
pDCs amplify tissue-resident memory CD8+ T cell responses during viral reinfection
Resident memory CD8+ T cells (Trms) are essential for protecting barrier nonlymphoid tissues (NLTs) against reinfection, yet the involvement of dendritic cells (DCs) in this process and the nature of Trm–DC interactions within these tissues remain poorly understood. Our study demonstrates that upon reactivation, memory CD8+ T cells located in the skin—independently of circulating memory counterparts—initiate the infiltration and maturation of plasmacytoid DCs (pDCs) in the tissue. This, in turn, promotes the maturation of conventional type 1 DCs (cDC1s) through type I IFN (IFN-I) signaling in a pDC-dependent manner. Depletion of pDCs or blocking IFN-I signaling disrupts this axis, severely impairing Trm-driven protection against secondary infections with vaccinia virus (VACV) in the skin. Notably, this pDC-dependent, IFN-I-mediated pathway is also essential for Trm-mediated protection against secondary respiratory infections with influenza A virus (IAV). Our findings uncover a crucial collaboration between Trm, pDCs, and cDC1s, offering new insights for enhancing vaccines.
- 25 November 2025
- Published by Rockefeller University Press in Journal of Experimental Medicine
- Vol. 223 (2)
pDCs amplify tissue-resident memory CD8+ T cell responses during viral reinfection
Resident memory CD8+ T cells (Trms) are essential for protecting barrier nonlymphoid tissues (NLTs) against reinfection, yet the involvement of dendritic cells (DCs) in this process and the nature of Trm–DC interactions within these tissues remain poorly understood. Our study demonstrates that upon reactivation, memory CD8+ T cells located in the skin—independently of circulating memory counterparts—initiate the infiltration and maturation of plasmacytoid DCs (pDCs) in the tissue. This, in turn, promotes the maturation of conventional type 1 DCs (cDC1s) through type I IFN (IFN-I) signaling in a pDC-dependent manner. Depletion of pDCs or blocking IFN-I signaling disrupts this axis, severely impairing Trm-driven protection against secondary infections with vaccinia virus (VACV) in the skin. Notably, this pDC-dependent, IFN-I-mediated pathway is also essential for Trm-mediated protection against secondary respiratory infections with influenza A virus (IAV). Our findings uncover a crucial collaboration between Trm, pDCs, and cDC1s, offering new insights for enhancing vaccines.